BRCA & Beyond
BRCA & Beyond is where real talk meets real life with a gene mutation. I’m Marisa, a BRCA2 previvor, colon cancer survivor, wife, and mom of two, and I know firsthand how overwhelming, emotional, and downright confusing this journey can be.
- Indexed episodes, last 90 days
- 11
- Latest publication
- Sep 8, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 10, 2026
Latest episodes
What Do Fallopian Tubes Have to Do With Ovarian Cancer? (Ovarian Cancer Awareness Series, Part 3 of 9) (opens the original)
Read excerpt
What do your fallopian tubes have to do with ovarian cancer risk? Research has changed the way we understand ovarian cancer, including evidence that many high-grade serous ovarian cancers may actually begin in the fallopian tubes. That discovery has opened the door to an important question for people with hereditary ovarian cancer risk: could removing the fallopian tubes first allow some people to keep their ovaries longer? In this episode of BRCA & Beyond’s Ovarian Cancer Awareness Month series
There Is No Reliable Ovarian Cancer Screening Test. So What Are We Doing? (Ovarian Cancer Awareness Series, Part 2 of 9) (opens the original)
Read excerpt
There is no reliable screening test for ovarian cancer. So what are we actually doing when we go in for CA125 blood work and a transvaginal ultrasound? This is Episode 2 of 9 in our Ovarian Cancer Awareness Month series on BRCA & Beyond. Host Marisa Stachelski, a BRCA2 previvor and colon cancer survivor, breaks down the difference between screening and surveillance and why that one word causes so much confusion for people living with hereditary ovarian cancer risk. CA125 and transvaginal ultraso
You Have a Higher Risk of Ovarian Cancer. Now What? (Ovarian Cancer Awareness Series, Part 1 of 9) (opens the original)
Read excerpt
You have an increased risk of ovarian cancer. Now what? This is Episode 1 of 9 in our Ovarian Cancer Awareness Month series, where we spend September looking at ovarian cancer through the lens of hereditary cancer risk. Host Marisa Stachelski, a BRCA2 previvor, colon cancer survivor, and your guide through hereditary cancer risk, breaks down what "increased risk" actually means once you get past the scary headline. BRCA1, BRCA2, BRIP1, RAD51C, RAD51D, and Lynch syndrome can all raise ovarian can
Jackie Wendell: Lynch Syndrome, Medical Dismissal & Uterine Cancer at 30 (opens the original)
Read excerpt
In this episode of BRCA & Beyond , Marisa sits down with Jackie Wendell , a Lynch Syndrome advocate and uterine cancer survivor, for an honest conversation about hereditary cancer risk, medical dismissal, genetic testing, and learning to advocate for yourself when you know something isn’t right. Jackie grew up with a significant family history of cancer, but it wasn’t until her own uterine cancer diagnosis at just 30 years old that genetic testing confirmed Lynch Syndrome and an MSH2 mutation .
One Year of BRCA & Beyond: The Hereditary Cancer Podcast I Needed (opens the original)
Read excerpt
BRCA & Beyond is officially one year old. In this anniversary episode, I’m sharing how my experience as a BRCA2 previvor and colon cancer survivor led me to create the hereditary cancer podcast I once needed but couldn’t find. I take you back to the very first episode recorded at my kitchen counter, reveal the unexpected story behind the name BRCA & Beyond, and reflect on how one small idea grew into a community for people navigating BRCA1, BRCA2, Lynch syndrome, PALB2, CHEK2, ATM, and other inh
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.